Promises and potential pitfalls of long-acting injectable pre-exposure prophylaxis
The number of products that can provide pre-exposure prophylaxis (PrEP) for HIV prevention is expanding, with three now approved in South Africa (oral Tenofovir-based PrEP, injectable Cabotegravir, and a Dapivirine-based vaginal ring) and more in the development pipeline. Although highly effective a...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AOSIS
2023-07-01
|
| Serier: | Southern African Journal of HIV Medicine |
| Fag: | |
| Online adgang: | https://sajhivmed.org.za/index.php/hivmed/article/view/1497 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
